Frontiers | Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
A renal cell carcinoma tumorgraft platform to advance precision medicine - ScienceDirect
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review: Molecular Therapy - Nucleic Acids
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics | Communications Biology
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect
Biomarkers in renal cell carcinoma: Are we there yet? - ScienceDirect
Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research | British Journal of Cancer
Cancers | Free Full-Text | From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine
Synthetic biomarkers: a twenty-first century path to early cancer detection | Nature Reviews Cancer
Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors - eBioMedicine
Frontiers | The Identification of Immunological Biomarkers in Kidney Cancers
The immunology of renal cell carcinoma | Nature Reviews Nephrology
Frontiers | The Identification of Immunological Biomarkers in Kidney Cancers
Exosomes as a Multicomponent Biomarker Platform in Cancer: Trends in Cancer
Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition - ScienceDirect
Renal cancer biomarkers: the promise of personalized care | BMC Medicine | Full Text
Biomarkers in drug discovery and development
Diseases | Free Full-Text | Proficient Novel Biomarkers Guide Early Detection of Acute Kidney Injury: A Review
Cabozantinib Slows Progression of Rare Kidney Cancer - NCI
What is a Biomarker? | Lippincott NursingCenter
The Hunt for Urinary Biomarkers to Diagnose Kidney Cancer - Johns Hopkins Medicine
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Determinants of renal cell carcinoma invasion and metastatic competence | Nature Communications
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population | Nature Communications
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach - eBioMedicine
Renal cell carcinoma: the search for a reliable biomarker - Farber - Translational Cancer Research
Prognostic and predictive biomarkers in Renal Cell Carcinoma. | Download Table
